¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"calcific mitral disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • functional cardiovascular disease
    ±â´É¼º½É(Àå)Ç÷°üº´
  • fungal disease
    Áø±ÕÁúȯ, °õÆÎÀ̺´
  • fusospirochetal disease
    ¹æÃß±Õ½ºÇÇ·ÎÇ쟺´
  • gastroesophageal reflux disease
    À§½Äµµ¿ª·ùº´
  • genetic disease
    À¯Àüº´
  • gestational trophoblastic disease
    Àӽſµ¾ç¸·º´
  • glomerular disease
    Å丮º´, »ç±¸Ã¼Áúȯ
  • gamma chain disease
    °¨¸¶»ç½½º´
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûº´, ´ç¿øÃàÀûº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • granulomatous disease
    À°¾ÆÁ¾º´
  • Greenfield¡¯s disease
    ±×¸°Çʵ庴
  • Hartnup¡¯s disease
    ÇÏÆ®³Òº´
  • Hashimoto¡¯s disease
    ÇϽøðÅ亴
  • hyperendemic disease
    °ú´ÙºóµµÇ³Å亴, °ú´ÙÁö¹æÀ¯Çິ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • generalized obstructive lung disease
    ¹ü¹ßÆó¼âÆóº´
  • genetic disease
    À¯Àüº´
  • gestational trophoblastic disease
    Àӽſµ¾ç¸ð¼¼Æ÷º´
  • glucose storage disease
    ´çÃàÀûº´
  • glycogen storage disease
    ´ç¿øÃàÀûº´
  • graft-versus-host disease
    À̽Ĵë¼÷ÁÖº´
  • granulomatous disease
    À°¾ÆÁ¾º´
  • hand-foot-mouth disease
    ¼Õ¹ßÀÔº´
  • Hansen¡¯s disease
    (¢¡leprosy) ³ªº´
  • hard pad disease
    °æÃ´Áõ
  • heart disease
    ½ÉÀ庴
  • heart muscle disease
    ½ÉÀå±ÙÀ°º´
  • heavy-chain disease
    Áß°í¸®º´
  • helminthic disease
    ¿¬Ã溴
  • hemisoimmune disease
    ÀûÇ÷±¸µ¿Á¾¸é¿ªº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • Oguchis disease
    ¿À±¸Ä¡º´
  • Osler-Weber-Rendu disease
    ¿À½½·¯-¿þ¹ö-·»µÎ¾¾ º´
  • Pagets disease
    ÆÄÁ¦Æ®º´
  • Pagets disease
    ÆÄÁ¦Æ®º´.
  • Pagets disease
    ÆÄÁ¦Æ®º´
  • Pagets disease, extramammary
    À¯¹æ¿Ü ÆÄÁ¦Æ®º´.
  • Parkinsons disease
    ÆÄŲ½¼º´
  • Parkinsons disease
    ÆÄŲ½¼º´.
  • Pick s disease
    ÇȺ´.
  • Picks disease
    ÇÇÅ©º´(~Ü»)
  • Pompe disease
    ÆûÆäº´
  • Pompes disease
    ÆûÆä¾¾ º´
  • Pott s disease
    Æ÷Æ®º´ ôÃßÄ«¸®¿¡½º .
  • Potts disease
    Æ÷Æ®º´, ôÃßÄ«¸®¿¡½º .
  • Pseudo Hurler disease
    °¡¼ºÇæ·¯º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • bird fanciers disease
    Á¶·ù»çÀ°ÀÚº´.
  • bird fanoiers disease
    Á¶·ù»çÀ°ÀÚº´(ðè×¾ÞøëÀí­Ü»)
  • black disease
    ±«»ç¼º °£¿°(ÎÕÞÝàõÊÜæú) ¡ì¾çÀÇ¡í.
  • black disease
    ±«»ç¼º °£¿°(ÎÕÞÝàõÊÜæú) ¡ì¾çÀÇ¡í.
  • black jaundice =Winckels disease
    ÈæÈ²´Þ(ÈæÈ²´Þ).
  • black jaundice =Winckels disease
    ÈæÈ²´Þ(ýÙüÜÓ¸).
  • bleeders disease
    Ç÷¿ìº´(úìéÒ Ü»).
  • blistering(bullous) disease
    ¼öÆ÷¼ºÁúȯ(¡­òðü´)
  • blood disease
    Ç÷¾×Áúȯ
  • bloodgoods disease
    Bloodgood º´ (¡­Ü»)
  • blue disease
    û»öº´(ôìßäÜ»).
  • bone disease
    °ñÁúȯ
  • bone disease =osteopathy
    °ñ Áúȯ(Íéòðü´).
  • bone disease, marble
    ´ë¸®¼® °ñÁúȯ
  • bournevilles disease
    ºÎ¸£´Àºä º´(¡­Ü»)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
MR   1) Mitral Regurgitation
    = MI
  2) Minor Response...
MS   1) Mitral Stenosis
  2) Multiple Sclerosis; ´Ù¹ß¼º °æÈ­Áõ
  3) Macro...
MV Mitral Valve
MVP Mitral Valve Prolapse; ½Â¸ðÆÇ Å»Ãâ
SAM Systolic Anterior Motion( of mitral valve); ¼öÃà±â Àü¹æ ¿îµ¿
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
ADV Aleutian mink disease parvovirus
AHD Alveolar hydatid disease
ADAS Alzheimer Disease Assessment Scale
ADAS-Cog Alzheimer Disease Assessment Scale--Cognitive subscale
ACD Anaemia of chronic disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • immunologic disease
    ¸é¿ª Áúȯ, ¸é¿ªÇÐÀû Áúȯ
  • inclusion body disease
    ºÀÀÔü º´
    ¼¼Æ÷ ºÀÀÔü°¡ ³ªÅ¸³ª´Â Áúȯ. ƯÈ÷ ¹ÙÀÌ·¯½º º´¿¡¼­ ÈçÇÏ´Ù.
  • infectious disease
    °¨¿° Áúȯ, °¨¿°¼º Áúȯ, °¨¿°º´, Àü¿°º´
    °¨¿°À» ÀÏÀ¸Å°´Â ¼÷ÁÖ´Â Á¦°¢±â º´¿øÃ¼¿¡ ´ëÇØ¼­ ƯÀ¯ÇÑ ¹ÝÀÀÀ» ³ªÅ¸³»°í ¹ÝÀÀÀÇ º´ÀûÀÎ Á¤µµ¿¡ ´ÞÇØ ÀÓ»ó Áõ»óÀÌ ³ªÅ¸³­ ÁúȯÀ» ¸»ÇÑ´Ù. °¨¿°À» ÀÏÀ¸Äѵµ ¹Ýµå½Ã ¹ßº´ÇÑ´Ù°í´Â ÇÒ ¼ö ¾ø°í ±× º´¿øÃ¼ÀÇ Á¾·ù, º´¿øÃ¼ÀÇ °¨¿°·Â¿¡ °üÇÑ ÀÎÀÚ¿Í °¨¿°ÇÑ »ýüÀÇ °¨¼ö¼º, ¸é¿ª, ±× ¹ÛÀÇ ÀúÇ׷¿¡ °üÇÑ ÀÎÀÚ¿ÍÀÇ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ¼­ °áÁ¤µÈ´Ù.
  • ischemic heart disease
    ÇãÇ÷¼º ½É Áúȯ
  • Jadassohn's disease
    ¾ß´ÙÁ¸ º´
    ¹Ý»ó ±¸Áø»ó È«ÇÇÁõ.
  • Jod-Basedow disease
    Jod-Basedow Áúȯ
    ¿ä¿Àµå À¯¹ß¼ºÀÇ °©»ó¼± ±â´É Ç×ÁøÁõ.
  • jumping disease
    ¹«µµº´
  • Kahler's disease
    Kahler º´
    ´Ù¹ß¼ºÀÇ °ñ¼öÁ¾À¸·Î ÀϹÝÀûÀÎ °ñ ¼¼Æ÷¿¡¼­ º¼ ¼ö ÀÖ´Â Á¾¾ç.
  • Kawasaki disease
    °¡¿Í»çŰ º´
    °©ÀÛ½º·± ¿­°ú Àü½Å¿¡ ¹ßÁøÀÌ ³ªÅ¸³ª´Â ¿øÀÎ ºÒ¸íÀÇ Áúȯ. 1967³â ÀϺ»¿¡¼­ óÀ½À¸·Î º¸°íµÈ µ¥¼­ ÀÌ·± º´¸íÀÌ ºÙ¾ú´Ù. È«¿ª, ¼ºÈ«¿­, dzÁø µî°ú ºñ½ÁÇÑ Áõ¼¼¸¦ º¸À̹ǷΠ°¨º°¿¡ À¯ÀÇÇØ¾ß ÇÑ´Ù. Áõ¼¼·Î´Â, ¨ç °í¿­ÀÌ 5ÀÏ ÀÌ»ó °è¼ÓµÈ´Ù. ¨è ´«ÀÌ ÃæÇ÷µÈ´Ù. ¨é ¼Õ¹Ù´Ú, ¹ß¹Ù´ÚÀÌ »¡°²°Ô ºÎ¾î¿À¸£¸é¼­ ²®ÁúÀÌ ¹þ°ÜÁø´Ù. ¨ê Àӯļ±ÀÌ º×´Â´Ù. ¨ë ÀÔ¼úÀÌ ºÓ¾îÁø´Ù. ¨ì Àü½Å ¹ßÁø Áõ¼¼ µîÀ» º¸À̴µ¥, ÀÌ °¡¿îµ¥ 5°¡Áö ÀÌ»óÀÇ Áõ¼¼¸¦ º¸À̸é ÀÌ º´À» ÀǽÉÇØ¾ß ÇÑ´Ù. ¹ÙÀÌ·¯½º °¨¿°¼³, Áß¼º ¼¼Á¦¼³, Ä­µð´Ù ¼¼±Õ¼³ µîÀÌ ¿øÀÎÀ̶ó´Â Çм³ÀÌ Á¦±âµÇ¾úÀ¸³ª È®½ÇÇÏ°Ô ¹àÇôÁöÁö ¾Ê°í ÀÖ´Ù. 90 % ÀÌ»óÀÌ 1~4¼¼ÀÇ ¿µ, À¯¾Æ±â¿¡ ¹ßº´Çϸç, ¿©¾Æº¸´Ù´Â ³²¾Æ¿¡°Ô ÁÖ·Î ¹ßº´ÇÑ´Ù. ¶ÇÇÑ ¹ßº´·üÀÌ ¼­¾çÀκ¸´Ù µ¿¾çÀο¡°Ô ³ô´Ù. ¿¹¹æ¹ýÀº ÇöÀç µû·Î ¾ø°í Áõ¼¼¸¦ º¸ÀÎ ÈÄ 2~3ÁÖ¸é ÀÚ¿¬ Ä¡À¯µÇ³ª ½ÉÀå ÇÕº´ÁõÀ» ÀÏÀ¸ÄÑ ±Þ»çÇÒ À§ÇèÀÌ ÀÖ´Â Áúº´À̱⵵ ÇÏ´Ù. µû¶ó¼­ Á¶±â¿¡ ¹ß°ßÇÏ¿© ÇÕº´ÁõÀ» ¿¹¹æÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù. Çѱ¹¿¡¼­´Â 73³â óÀ½À¸·Î ¹ß°ßµÈ ÀÌ·¡ 91³â 1, 228¸íÀÌ ¹ßº´, º¸°íµÇ¾ú´Ù.
  • Kimura disease
    Ű¹«¶ó º´
    ûÀå³â±âÀÇ ¿©ÀÚ¿¡°Ô ÁÖ·Î ¹ß»ýµÇ´Â ¸Æ¶õ¼º Áõ½Ä¼º º´¼ÒÀÌ´Ù. µÎ°æºÎ ÇÇÇÏ Á¶Á÷À̳ª ±¸°­³» ¶Ç´Â »ó¼ø ³»Ãø¿¡¼­ Àß ¹ß»ýµÇ¸ç ÀÌÇϼ± ºÎÀ§¿¡¼­µµ ÀÚÁÖ º¸ÀδÙ. Á¶Á÷ÇÐÀûÀ¸·Î ÀÌÇü¼º Ç÷°ü ³»ÇÇ ¼¼Æ÷ÀÇ Áõ½Ä°ú ¸¸¼º ¿°Áõ ¼¼Æ÷ÀÇ Ä§À±, È£»ê±¸ÀÇ Ä§À±ÀÌ ÀÖ°í ½ÉÇϸé È£»ê±¸ ³ó¾çµµ Çü¼ºÇÏ¸ç ¸²ÇÁ Á¶Á÷ÀÇ Áõ»óÀ» º¸ÀδÙ. Ÿ¾×¼± Á¶Á÷Àº À§ÃàµÇ°í ÀÖ´Ù.
  • Lane's disease
    ·¹ÀÎ º´
    ¸¸¼º Àå Æó»öÁõ.
  • Langdon-Down's disease
    ·©µ·-´Ù¿î º´
  • Larsen-Johansson disease
    ¶ó¸£¼¾-¿äÇѽ¼ º´
  • law of prophylaxis for infectious disease
    Àü¿°º´ ¿¹¹æ¹ý
  • legal communicable disease
    ¹ýÁ¤ Àü¿°º´
    Àü¿°º´ ¿¹¹æ¹ý Á¦2Á¶ 1Ç׿¡¼­ ¿­°Å ±ÔÁ¤Çϰí ÀÖ´Â Àü¿°º´. Á¦1Á¾, Á¦2Á¾ ¹× Á¦3Á¾À¸·Î ³ª´©¾îÁø´Ù. 93³â 12¿ù ¼öÁ¤, °áÁ¤µÈ ¹ýÁ¤ Àü¿°º´Àº ¸ðµÎ 28Á¾ÀÌ´Ù. Áï, Á¦1Á¾Àº ÄÝ·¹¶ó, Æä½ºÆ®, ¹ßÁøÆ¼Çª½º, ÀåÆ¼Çª½º, ÆÄ¶óƼǪ½º, µðÇÁÅ׸®¾Æ, ¼¼±Õ¼º ÀÌÁú, Ȳ¿­, Á¦2Á¾Àº Æú¸®¿À, ¹éÀÏÇØ, È«¿ª, À¯Ç༺ ÀÌÇϼ±¿°, ÀϺ» ³ú¿°, °ø¼öº´, ¸»¶ó¸®¾Æ, ¹ßÁø¿­, ¼ºÈ«¿­, Àç±Í¿­, ¾Æ¸Þ¹Ù¼º ÀÌÁú, ¼ö¸· ±¸±Õ¼º ¼ö¸·¿°, À¯Ç༺ ÃâÇ÷¿­, ÆÄ»ódz, ÈÄõ¼º ¸é¿ª °áÇÌÁõ, ·¾Å佺ÇǶóÁõ, ¾²¾²°¡¹«½Ã º´, Á¦3Á¾Àº °áÇÙ, ¼ºº´, ³ªº´À¸·Î µÇ¾î ÀÖ´Ù. Àü¿°º´ ¿¹¹æ¹ýÀº ¹ýÁ¤ Àü¿°º´¿¡ ´ëÇÑ ÀÇ»ç, È£ÁÖ, ¼¼´ëÁÖ, ±âŸ °¢ ±â°üÀÇ ±â°üÀåÀ̳ª °æ¿µÀÚ, ±º ºÎ´ëÀå µîÀÇ ½Å°í ¹× º¸°í Àǹ«¿Í °Ç°­ Áø´Ü, ¿¹¹æ Á¢Á¾, °Ý¸®, ÀÔ¿ø Á¶Ä¡, °¢Á¾ ¿¹¹æ Á¶Ä¡ µîÀ» ±ÔÁ¤Çϰí ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
Bourneville-Pringle disease Facial lesions with tuberous sclerosis, first reported as adenoma sebaceum, but now recognised as angiofibromas.
(05 Mar 2000)
Bourneville's disease <radiology> (Bourneville disease) autosomal dominant phakomatosis classic triad: seizures, retardation, adenoma sebaceum, calcified subependymal hamartomas, uncalcified tubers in cerebral cortex, enhancing lesion most likely to be malignant transformation to giant cell astrocytoma associated with: skin lesions, angiomyolipoma, increased risk of renal cell carcinoma
(12 Dec 1998)
bovine virus diarrhoea-mucosal disease Acute disease of cattle caused by the bovine viral diarrhoea virus (diarrhoea virus, bovine viral). Often mouth ulcerations are the only sign but fever, diarrhoea, drop in milk yield, and loss of appetite are also seen. Mortality is high in animals showing clinical signs, especially diarrhoea.
(12 Dec 1998)
bowen's disease A persistent progressive non-elevated red scaly or crusted plaque which is due to an intradermal carcinoma and is potentially malignant. Atypical squamous cells proliferate through the whole thickness of the epidermis. The lesions may occur anywhere on the skin surface or on mucosal surfaces. The cause most frequently found is trivalent arsenic compounds. Freezing, cauterization or diathermy coagulation is often effective.
(12 Dec 1998)
Brailsford-Morquio disease <syndrome> An error of mucopolysaccharide metabolism with excretion of keratan sulfate in urine; characterised by severe skeletal defects with short stature, severe deformity of spine and thorax, long bones with irregular epiphyses but with shafts of normal length, enlarged joints, flaccid ligaments, and waddling gait; autosomal recessive inheritance; type IV A mucopolysaccharidosis is due to an absence of galactose-1-sulfatase, while type IV B is due to a deficiency of a beta-galactosidase.
Synonym: Brailsford-Morquio disease, Morquio's disease, Morquio-Ullrich disease, type IVA, B mucopolysaccharidosis.
(05 Mar 2000)
brancher glycogen storage disease Type of glycogen storage disease, due to deficiency of amylo-1,4-1,6-transglucosidase (brancher enzyme).
Synonym: brancher deficiency glycogenosis, debrancher deficiency.
(05 Mar 2000)
Breda's disease A type of American leishmaniasis caused by Leishmania braziliensis that affects the mucous membranes, particularly in the nasal and oral region, resulting in grossly destructive changes; particularly common in Brazil where a significant proportion of persons infected with L. Braziliensis develop this condition; may develop metastatically from sores originally found elsewhere on the body.
Synonym: Breda's disease, bubas braziliana.
Origin: Sp., fr. L. Spongia, sponge
(05 Mar 2000)
bright's disease <medicine> An affection of the kidneys, usually inflammatory in character, and distinguished by the occurrence of albumin and renal casts in the urine. Several varieties of Bright's disease are now recognised, differing in the part of the kidney involved, and in the intensity and course of the morbid process.
Origin: From Dr. Bright of London, who first described it.
Source: Websters Dictionary
(01 Mar 1998)
Brill's disease Recrudescence of epidemic typhus years after the initial attack. The agent that causes epidemic typhus (Rickettsia prowazekii) remains viable for many years and then when host defenses are down, it is reactivated causing recurrent typhus. The disease is named for the physician Nathan Brill and the great bacteriologist Hans Zinsser.
(12 Dec 1998)
Brill-Symmers disease An obsolete term for nodular lymphoma.
(05 Mar 2000)
brill-zinsser disease Recrudescence of epidemic typhus years after the initial attack. The agent that causes epidemic typhus (Rickettsia prowazekii) remains viable for many years and then when host defenses are down, it is reactivated causing recurrent typhus. The disease is named for the physician Nathan Brill and the great bacteriologist Hans Zinsser.
(12 Dec 1998)
Briquet's disease Hysterical neurosis, conversion type.
(05 Mar 2000)
brisket disease A disease of cattle, characterised by edematous swelling of the brisket and the tissues of the neck; the body cavities also contain large quantities of clear straw-coloured transudate; this disease results from right heart failure as a consequence of increased pulmonary resistance, which is in some way associated with movement of animals to high altitudes.
Synonym: mountain sickness.
(05 Mar 2000)
Brissaud's disease <clinical sign> An involuntary compulsive, repetitive, stereotyped movement, resembling a purposeful movement because it is coordinated and involves muscles in their normal synergistic relationships, tics usually involve the face and shoulders.
(18 Nov 1997)
broad beta disease Hyperlipoproteinaemia characterised by increased plasma levels of LDL, beta-lipoproteins, pre-beta-lipoproteins, cholesterol, phospholipids, and triglycerides; hypertriglyceridemia induced by a high carbohydrate diet, and glucose tolerance is abnormal; frequent eruptive xanthomas and atheromatosis, particularly coronary artery disease; biochemical defect lies in apolipoproteins; there are many varieties.
Synonym: carbohydrate-induced hyperlipaemia, dysbetalipoproteinaemia, familial hyperbetalipoproteinaemia and hyperprebetalipoproteinaemia, familial hypercholesterolaemia with hyperlipaemia.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á